News | September 12, 2007

Lung Cancer Alliance Stands Behind CT Screening

September 13, 2007 - While the American College of Chest Physicians (ACCP) came out this week in opposition to CT screening for lung cancer, Lung Cancer Alliance (LCA) reiterated its support for the screening test, which can detect lung cancer at its earliest most treatable stage for those at high risk.

"Mammograms for breast cancer faced enormous opposition for decades and there is still heated debate over screening of women under the age of 50. And there are reams of papers showing no mortality benefit for PSA testing for prostate cancer," said Laurie Fenton Ambrose, President of Lung Cancer Alliance.

"These scientific debates are not new, especially when it comes to interpreting statistics about the true benefit of screening," she said. "However it is disappointing and frankly shocking that the ACCP would flatly oppose CT screening for those at high risk for lung cancer when even the government health agency responsible for setting diagnostic guidelines is more balanced," she said.

The U.S. Preventive Services Task Force neither supports nor opposes screening for lung cancer, a neutral stance that it also takes on PSA testing for prostate cancer and breast self-exams for breast cancer.

"It is difficult to take the ACCP guidelines seriously when they are dismissive of screening and only endorse massages and acupuncture for a disease as deadly as lung cancer," she said.

The issue of early detection is critical in lung cancer which is the biggest cancer killer, taking more lives each year than breast, prostate, colon and kidney cancers combined. By the time symptoms, such as a cough or bloody sputum, appear it is usually too late and in most cases death occurs in less than a year.

Since last year, LCA has raised questions and concerns about the validity of underlying assumptions and modeling being used to provide the basis for the ACCP practice guidelines.

Harvey Pass MD, Chief of Thoracic Surgery and Thoracic Oncology at NYU School of Medicine, LCA Board member and chair of LCA's Medical and Scientific Advisory Board said: "These guidelines simply dismiss the mounting evidence which continues to mature from the largest international, protocol-driven screening effort (I-ELCAP) showing that CT screening in a high risk population has the potential to reverse the current 15% five year survival rate."

For more information: www.LungCancerAlliance.org

Related Content

Researchers Awarded 2018 Canon Medical Systems USA/RSNA Research Grants
News | Radiology Imaging | November 13, 2018
The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation recently announced the...
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
MaxQ AI Receives FDA Clearance for Accipio Ix Intracranial Hemorrhage Platform
Technology | Artificial Intelligence | November 07, 2018
MaxQ AI announced that its Accipio Ix intracranial hemorrhage (ICH) detection software has received 510(k) clearance...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Results of the vertebrae-based analysis (383 vertebrae in 34 patients) for detection of BME.

Results of the vertebrae-based analysis (383 vertebrae in 34 patients) for detection of BME.

Sponsored Content | Case Study | Computed Tomography (CT) | November 06, 2018
The following is a summary of a study published in the
The NeuViz 16 Essence from Neusoft Medical Systems.

The NeuViz 16 Essence from Neusoft Medical Systems.

Feature | Computed Tomography (CT) | November 05, 2018 | By Melinda Taschetta-Millane
According to an industry mark...
Carestream Spotlights Healthcare IT and Imaging Systems at RSNA 2018
News | Information Technology | October 31, 2018
Carestream announced it will be displaying several imaging and healthcare information technology (IT) offerings at the...
IMRIS, Siemens Strengthen Collaboration in Hybrid OR Neurosurgical Market
News | Hybrid OR | October 24, 2018
IMRIS, Deerfield Imaging, in partnership with Siemens Healthineers, announced a strengthened collaboration to advance...
Fujifilm Unveils FCT Embrace CT System for Oncology
Technology | Computed Tomography (CT) | October 23, 2018
Fujifilm Medical Systems U.S.A. Inc. recently introduced the FCT Embrace computed tomography (CT) system. Powered by...
The Aquilion Precision CT system from Canon offers very high resolution imaging, which may aid in cancer detection and improved treatment planning in radiation oncology. #ASTRO2018 #ASTRO #ASTRO18

The Aquilion Precision CT system from Canon offers very high resolution imaging, which may aid in cancer detection and improved treatment planning in radiation oncology. 

News | Computed Tomography (CT) | October 19, 2018
October 19, 2018 – At the 2018 American Society of...